Carelane
| Invested since | 2023 |
| Based in |
About the company
Carelane is a health tech startup focused on addressing the inefficiencies in clinical trials by integrating multiple essential functions into a single, streamlined system, thereby digitizing study protocols and processes. After launching in 2023, it quickly gained traction and closed its first funding round successfully in the beginning of 2024. Both founders have extensive experience working in health tech, having worked with the German government, private enterprises, and renowned research hospitals. They are driven by the vision to empower researchers and healthcare professionals, ultimately saving time that can be redirected towards groundbreaking research and innovations. Carelane stands at the forefront of transforming the clinical trial process, making it intuitive, efficient, and seamlessly integrated.
Do you want to
know more about this company?
More startups from Life Sciences
Coramaze Technologies develops an innovative, highly differentiated, transcatheter tricuspid valve repair system, called TriPair. Headquartered in Germany with an R&D hub in Israel, we promote health equity by offering a …
IOP GmbH will initiate a paradigm chance in glaucoma therapy by its products for telemetric, 24 hour monitoring of intraocular pressure, allowing personalized patient management.
SciRhom GmbH is a therapeutic antibody company developing first-in-class antibodies against iRhom2, a key modulator of several major pro-inflammatory signaling pathways, including TNF-alpha signaling. Based on a decade of cutting-edge …
In order to successfully treat the infected patient, you have to recognize and diagnose most reliably the infecting microbe. Noscendo changes the way infection causative microbes are identified. Through a …
Sierra Sensors is combining state of the art label-free detection with cutting edge microfluidic sample delivery, sensor design, and automation, to supply researchers with high performance analytical biosensors.
